Pharming Group N.V. (LON:0QCO)
0.9676
+0.0165 (1.74%)
At close: May 30, 2025
Pharming Group Revenue
Pharming Group had revenue of $79.09M USD in the quarter ending March 31, 2025, with 42.29% growth. This brings the company's revenue in the last twelve months to $320.71M, up 24.13% year-over-year. In the year 2024, Pharming Group had annual revenue of $297.20M with 21.15% growth.
Revenue (ttm)
$320.71M
Revenue Growth
+24.13%
P/S Ratio
2.42
Revenue / Employee
$793.83K
Employees
404
Market Cap
600.60M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 297.20M | 51.88M | 21.15% |
Dec 31, 2023 | 245.32M | 39.69M | 19.30% |
Dec 31, 2022 | 205.62M | 6.75M | 3.39% |
Dec 31, 2021 | 198.87M | -13.30M | -6.27% |
Dec 31, 2020 | 212.17M | 22.79M | 12.03% |
Jan 1, 2020 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
HSBC Holdings | 44.89B |
Shell | 217.54B |
Unilever | 50.25B |
British American Tobacco p.l.c. | 25.87B |
Rio Tinto Group | 42.86B |
Rolls-Royce Holdings | 18.91B |
RELX PLC | 9.43B |